Skip to content

Genome-wide analysis of advanced lung cancer cases that showed marked response to chemotherapy resulting in a treatment-free long-term remission

Genome-wide analysis of advanced lung cancer cases that showed marked response to chemotherapy resulting in a treatment-free long-term remission - Genome-wide analysis of advanced lung cancer cases that showed marked response to chemotherapy resulting in a treatment-free long-term remission

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000037822
Enrollment
10
Registered
2019-08-28
Start date
2019-08-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, Mesothelioma

Interventions

None listed

Sponsors

Division of Respiratory Medicine and Allergology, Aichi Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Stage IV lung cancer or mesothelioma with pathological confirmation 2. Age 20 or older 3. Lung cancer or mesothelioma in remission (complete remission or partial remission) that is achieved by chemotherapy and maintained without any cancer treatment for 2 years or longer after the last dose of chemotherapy 4. Available tumor tissue before chemotherapy for DNA and protein analysis 5. Available peripheral blood sample for DNA extraction as a non-cancerous reference 6. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Active double cancer (patients with treatment-free and disease-free state for 3 years or longer after a curative treatment are eligible) 2. Unsuitable to enter this study judged by an attending physician

Design outcomes

Primary

MeasureTime frame
Exploratory assessment of somatic alterations in advanced lung cancer related to marked response to chemotherapy and treatment-free long-term remission

Countries

Japan

Contacts

Public ContactAKIHITO KUBO

Aichi Medical University School of Medicine Division of Respiratory Medicine and Allergology

kuboa@aichi-med-u.ac.jp81-561-62-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026